I am a
Home I AM A Search Login

Papers of the Week


Papers: 7 Sep 2019 - 13 Sep 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 Sep


Headache


59


8

Prognosis Following Discontinuation of OnabotulinumA Therapy in “Super-responding” Chronic Migraine Patients.

Authors

Abstract

To determine whether the successful treatment of chronic migraine (CM) with onabotulinumA (BotoxA) may be followed by a continued respite from headache once therapy has been discontinued.